This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Zions Bancorporation National Association (ZION) Receives a Sell from Barclays

Tipranks - Tipranks - Fri Jun 26, 3:32AM CDT

Barclays analyst Jason Goldberg maintained a Sell rating on Zions Bancorporation National Association today and set a price target of $72.00.

TipRanks' Prime Week Sale - 70% Off

According to TipRanks, Goldberg is a 5-star analyst with an average return of 14.7% and a 70.02% success rate. Goldberg covers the Financial sector, focusing on stocks such as Citigroup, Truist Financial, and KeyCorp.

Currently, the analyst consensus on Zions Bancorporation National Association is a Hold with an average price target of $68.69.

See the top stocks recommended by analysts >>

Based on Zions Bancorporation National Association’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.18 billion and a net profit of $233 million. In comparison, last year the company earned a revenue of $1.2 billion and had a net profit of $170 million

Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ZION in relation to earlier this year. Last month, Jennifer Anne Smith, the EVP of ZION sold 4,209.00 shares for a total of $263,062.50.

Read More on ZION:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).